Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis - PubMed
5 hours ago
- #Primary Prevention
- #LDL-C
- #Cardiovascular Risk
- Meta-analysis examines LDL-C lowering and MACE risk in primary prevention trials.
- Pooled results show a 30% relative risk reduction in MACE per 1 mmol/L LDL-C reduction.
- Includes trials with statin and nonstatin therapies, reinforcing benefits of LDL-C lowering in primary prevention.
- Study strengthens evidence for LDL-C lowering in reducing cardiovascular events in primary prevention settings.